scholarly article | Q13442814 |
P50 | author | Piero Olliaro | Q72250873 |
Michael Woelfle | Q124657543 | ||
Matthew H. Todd | Q29017168 | ||
P2093 | author name string | Jean-Paul Seerden | |
Kees Pouwer | |||
Jesse de Gooijer | |||
P2860 | cites work | Open science is a research accelerator | Q21004179 |
Taste, a new incentive to switch to (R)-praziquantel in schistosomiasis treatment | Q21090121 | ||
Identification of oxadiazoles as new drug leads for the control of schistosomiasis | Q24642230 | ||
Schistosomiasis | Q28215200 | ||
Quantitative high-throughput screen identifies inhibitors of the Schistosoma mansoni redox cascade | Q28472122 | ||
Reduced susceptibility to praziquantel among naturally occurring Kenyan isolates of Schistosoma mansoni | Q28475935 | ||
Drug-resistant schistosomiasis: resistance to praziquantel and oxamniquine induced in Schistosoma mansoni in mice is drug specific. | Q54199827 | ||
Praziquantel | Q56656935 | ||
Comparison of the therapeutic efficacy and side effects of a single dose of levo-praziquantel with mixed isomer praziquantel in 278 cases of schistosomiasis japonica | Q68025820 | ||
Comparative in vitro and in vivo activity of racemic praziquantel and its levorotated isomer on Schistosoma mansoni | Q69943322 | ||
Comparative efficacy of praziquantel and its optic isomers in experimental therapy of schistosomiasis japonica in rabbits | Q70336138 | ||
Praziquantel derivatives I: Modification of the aromatic ring | Q80446307 | ||
The Family Approach to the Resolution of Racemates | Q95526529 | ||
Mesenteric venous thrombosis | Q95783577 | ||
Interactions d'enantiomeres en solution ; influence sur le pouvoir rotatoire : Purete optique et purete enantiomerique. | Q114738731 | ||
Reassessment of the cost of chronic helmintic infection: a meta-analysis of disability-related outcomes in endemic schistosomiasis | Q29619819 | ||
Susceptibility to praziquantel of male and female cercariae of praziquantel-resistant and susceptible isolates of Schistosoma mansoni | Q33504927 | ||
Towards an understanding of the mechanism of action of praziquantel | Q33914691 | ||
The global status of schistosomiasis and its control | Q34510931 | ||
Resistance of Schistosoma mansoni to praziquantel: is there a problem? | Q35021630 | ||
Drugs for the control of parasitic diseases: current status and development in schistosomiasis | Q35569078 | ||
Chemotherapy of schistosomiasis: present and future | Q36891317 | ||
Praziquantel: mechanisms of action, resistance and new derivatives for schistosomiasis | Q37315241 | ||
Process evaluation of schistosomiasis control in Uganda, 2003 to 2006: perceptions, attitudes and constraints of a national programme | Q38873931 | ||
Resisting control of neglected tropical diseases: dilemmas in the mass treatment of schistosomiasis and soil-transmitted helminths in north-west Uganda | Q38877533 | ||
Africa is desperate for praziquantel | Q39078359 | ||
Efficient multicomponent reaction synthesis of the schistosomiasis drug praziquantel. | Q42906063 | ||
Praziquantel analogs with activity against juvenile Schistosoma mansoni | Q43123274 | ||
In vitro responses of praziquantel-resistant and -susceptible Schistosoma mansoni to praziquantel | Q43713527 | ||
A comparison of the antischistosomal effect of levo- and dextro-praziquantel on Schistosoma japonicum and S. mansoni in mice | Q44619194 | ||
Highly enantioselective catalytic acyl-pictet-spengler reactions | Q45028813 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 9 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | praziquantel | Q424145 |
infectious disease | Q18123741 | ||
P304 | page(s) | e1260 | |
P577 | publication date | 2011-09-01 | |
P1433 | published in | PLoS Neglected Tropical Diseases | Q3359737 |
P1476 | title | Resolution of praziquantel | |
P478 | volume | 5 |
Q58864744 | A comparison of the palatability of racemic praziquantel and its two enantioseparated isomers in yellowtail kingfish Seriola lalandi (Valenciennes, 1833) |
Q64947379 | A novel praziquantel solid lipid nanoparticle formulation shows enhanced bioavailability and antischistosomal efficacy against murine S. mansoni infection. |
Q55222741 | Activation of host transient receptor potential (TRP) channels by praziquantel stereoisomers. |
Q34057535 | Activity of praziquantel enantiomers and main metabolites against Schistosoma mansoni. |
Q51551327 | Decades down the line: the viability of praziquantel for future schistosomiasis treatment. |
Q33747366 | Design and synthesis of molecular probes for the determination of the target of the anthelmintic drug praziquantel |
Q39535453 | Enhancing the usefulness of cross dehydrogenative coupling reactions with a removable protecting group |
Q47178426 | Experiences with a researcher-centric ELN. |
Q47158108 | Experiences with a researcher-centric ELN† †Electronic supplementary information (ESI) available. See DOI: 10.1039/c4sc02128b Click here for additional data file |
Q28478606 | First Universities Allied for Essential Medicines (UAEM) Neglected Diseases and Innovation Symposium |
Q28543846 | Inhibition or knockdown of ABC transporters enhances susceptibility of adult and juvenile schistosomes to Praziquantel |
Q56054493 | MyExperimentalScience, extending the ‘workflow’ |
Q26883657 | Open Source Drug Discovery: Highly Potent Antimalarial Compounds Derived from the Tres Cantos Arylpyrroles |
Q21004179 | Open science is a research accelerator |
Q28660808 | Open source drug discovery - a limited tutorial |
Q21144491 | Open source drug discovery in practice: a case study |
Q39164325 | Praziquantel for Schistosomiasis: Single-Drug Metabolism Revisited, Mode of Action, and Resistance. |
Q26752354 | Schistosomiasis Prevalence and Intensity of Infection in Latin America and the Caribbean Countries, 1942-2014: A Systematic Review in the Context of a Regional Elimination Goal |
Q48478678 | Schistosomiasis and its treatment |
Q90709519 | Six Laws of Open Source Drug Discovery |
Q40045557 | Slow-release praziquantel for dogs: presentation of a new formulation for echinococcosis control |
Q46081944 | Synthesis and SAR studies of praziquantel derivatives with activity against Schistosoma japonicum. |
Q28678693 | Ten simple rules for cultivating open science and collaborative R&D; |
Q46247381 | The anthelmintic praziquantel is a human serotoninergic G-protein-coupled receptor ligand |
Q36083496 | The cytotoxicity study of praziquantel enantiomers |
Q28484503 | The outcome of the oxidations of unusual enediamide motifs is governed by the stabilities of the intermediate iminium ions |
Q38495068 | Toward organometallic antischistosomal drug candidates |
Q50881127 | Validated capillary electrophoretic method for the enantiomeric quality control of R-praziquantel. |
Q39004186 | What is the mechanism of action of praziquantel and how might resistance strike? |